News Industry News Corindus Vascular Robotics to Host Presentation on Robotic-Assisted PCI at TCT 2011 October 26, 2011
News Industry News Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent October 18, 2011
News Industry News PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S. October 14, 2011
News Industry News Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation October 10, 2011
News Industry News Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System October 05, 2011
News Industry News JenaValve Technology is first in receiving CE certification for a True Second-Generation Transapical TAVI System September 30, 2011
News Industry News Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial September 29, 2011
News Industry News Bayer AG: Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint September 29, 2011
News Industry News Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN September 27, 2011
News Industry News Medtronic Announces Start of Pivotal Trial for Engager™ Transcatheter Aortic Valve Implantation System September 27, 2011
News Industry News PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology September 22, 2011
News Industry News FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation September 08, 2011
News Industry News Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia September 08, 2011
News Industry News St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology August 31, 2011
News Industry News REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation August 18, 2011
News Industry News First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial August 16, 2011
News Industry News Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study August 15, 2011